Cargando…
PPAD: a deep learning architecture to predict progression of Alzheimer’s disease
MOTIVATION: Alzheimer’s disease (AD) is a neurodegenerative disease that affects millions of people worldwide. Mild cognitive impairment (MCI) is an intermediary stage between cognitively normal state and AD. Not all people who have MCI convert to AD. The diagnosis of AD is made after significant sy...
Autores principales: | Al Olaimat, Mohammad, Martinez, Jared, Saeed, Fahad, Bozdag, Serdar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311312/ https://www.ncbi.nlm.nih.gov/pubmed/37387135 http://dx.doi.org/10.1093/bioinformatics/btad249 |
Ejemplares similares
-
PPAD: A deep learning architecture to predict progression of Alzheimer’s disease
por: Al Olaimat, Mohammad, et al.
Publicado: (2023) -
Transfer learning for drug–target interaction prediction
por: Dalkıran, Alperen, et al.
Publicado: (2023) -
Optimizing blood–brain barrier permeation through deep reinforcement learning for de novo drug design
por: Pereira, Tiago, et al.
Publicado: (2021) -
AttOmics: attention-based architecture for diagnosis and prognosis from omics data
por: Beaude, Aurélien, et al.
Publicado: (2023) -
Investigation of REFINED CNN ensemble learning for anti-cancer drug sensitivity prediction
por: Bazgir, Omid, et al.
Publicado: (2021)